Cerebellar changes in partial seizures: Clinical correlations of quantitative SPECT and MRI analysis

Epilepsia

Volumn 39, Issue 6, 1998, Pages 640-650

  Bohnen, Nicolaas I ^a   O'Brien, Terence J ^a   Mullan, Brian P ^a   So, Elson L ^a  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

Cerebellar atrophy; Cerebellar hyperperfusion; MRI; Partial epilepsy; SPECT

Indexed keywords

ANTICONVULSIVE AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN PERFUSION; CEREBELLUM; CEREBELLUM ATROPHY; CHILD; FEMALE; FOCAL EPILEPSY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADOLESCENT; ADULT; AGED; ATROPHY; CEREBELLAR DISEASES; CEREBELLUM; CHILD; CHILD, PRESCHOOL; EPILEPSIES, PARTIAL; EPILEPSY, TEMPORAL LOBE; FEMALE; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; REGIONAL BLOOD FLOW; TECHNETIUM TC 99M EXAMETAZIME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME;

EID: 0031802089     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1998.tb01433.x     Document Type: Article

References (44)

1. Dam M. Number of Purkinje cells in patients with grand mal epilepsy treated with diphenylhydantoin. Epilepsia 1970;11:313-20.
2. Koller WC, Glatt SL, Perlik S, Huckman MS, Fox JH. Cerebellar atrophy demonstrated by computed tomography. Neurolgy 1982;32:910-2.
3. Luef G, Chemelli A, Birbamer G, Aichner F, Bauer G. Phenytoin overdosage and cerebellar atrophy in epileptic patients: clinical and MRI findings. Eur Neurol 1994;34(suppl 1):79-81.
4. Ney GC, Lantos G, Barr WB, Schaul N. Cerebellar atrophy in patients with long-term phenytoin exposure and epilepsy. Arch Neurol 1994;51:767-71.
5. Specht U, May T, Schulz R, et al. Cerebellar atrophy and prognosis after temporal lobe resection. J Neurol Neurosurg Psychiatry 1997;62:501-6.
6. Meldrum B. Physiological changes during prolonged seizures and epileptic brain damage. Neuropediatrie 1978;9:303-12.
7. Salcman M, Defendini R, Correll J, Oilman S. Neuropathological changes in cerebellar biopsies of epileptic patients. Ann Neurol 1978;3:10-9.
8. Zimmerman HM. The histopathology of convulsive disorders in children. J Pediatr 1938;13:859-90.
9. Ghatak NR, Santaso RA, McKinney WM. Cerebellar degeneration following long-term phenytoin therapy. Neurology 1976;26:818-20.
10. Lindvall O, Nielsson B. Cerebellar atrophy following phenytoin intoxication. Ann Neurol 1984;16:258-60.
11. Cooke PM, Snider RS. Some cerebellar influences on electrically-induced cerebral seizures. Epilepsia 1955;4:19-28.
12. Snider RS, Maiti A. Septal afterdischarges and their modification by the cerebellum. Exp Neurol 1975;49:529-39.
13. Hutton JT, Frost JD, Foster J. The influence of the cerebellum in cat penicillin epilepsy. Epilepsia 1972;13:401-8.
14. Cooper IS, Amin I, Upton A, et al. Safety and efficacy of chronic stimulation. Neurosurgery 1977;1:203-5.
15. Laxer KD, Robertson LT, Julien RM, et al. Phenytoin: relationship between cerebellar function and epileptic discharges. In: Glaser GH, Penry J, Woodbury DM, eds. Antiepileptic drugs: mechanism of action. New York: Raven Press, 1980:415-27.
16. Davis R, Emmonds SE. Cerebellar stimulation for seizure control: 17-year study. Stereotact Funct Neurosurg 1992;58:200-8.
17. Krauss GL, Fisher RS. Cerebellar and thalamic stimulation for epilepsy. In: Devinsky O, Beric A, Dogali M, eds. Electrical and magnetic stimulation of the brain and spinal cord. New York: Raven Press, 1993:231-45.
18. Tien RD, Ashdown BC. Crossed cerebellar diaschisis and crossed cerebellar atrophy: correlation of MR findings, clinical symptoms and supratentorial diseases in 26 patients. AJR Am J Roentgenol 1992;158:1155-9.
19. Von Monakow C. Die Lokalisation im Grosshirn und der Abbau der Funktion durch Kortikale Herde. Weisbaden: J. F. Bergman, 1914:26-34.
20. Meyer JS, Obara K, Muramatsu K. Diaschisis. Neurol Res 1993;15:362-6.
21. Baron JC, Bonsser MG, Comar D, Castaigne P. Crossed cerebellar diaschisis in human supratentorial brain infarction. Trans Am Neurol Assoc 1980;105:459-61.
22. Duncan R, Patterson J, Bone I, Wyper DJ. Reversible cerebellar diaschisis in focal epilepsy. Lancet 1987;2:625-6.
23. Won JH, Lee JD, Chung TS, Park CY, Lee BI. Increased contralateral cerebellar uptake of technetium-99m-HMPAO on ictal brain SPECT. J Nucl Med 1996;37:426-9.
24. Stübgen J-P. Crossed cerebellar diaschisis related to recurrent focal seizures. Epilepsia 1995;36:316-8.
25. Collins RC, Olney JW. Focal conical seizures cause distant thalamic lesions. Science 1982;218:177-9.
26. Clifford DB, Zorumski CF, Olney JW. Ketamine and MK-801 prevent degeneration of the thalamic neurones induced by focal cortical seizures. Exp Neurol 1989;105:272-9.
27. Strefling AM, Urich H. Crossed cerebellar atrophy: an old problem revisted. Acta Neuropathol 1982;57:197-202.
28. Pantano P, Baron JC, Samson Y, Bousser MG, Derouesne C, Comar D. Crossed cerebellar diaschisis. Brain 1986;109:677-94.
29. Engel J Jr, Van Ness P, Rasmussen T, Ojemann L. Outcome with respect to epileptic seizures. In: Engel J Jr, ed. Surgical treatment of the epilepsies. New York: Raven Press. 1993:609-21.
30. So EL, Radhakrishnan K, Silbert P, Cascino G, Sharbrough F, O'Brien P. Assessing changes over time in temporal lobectomy: outcome by scoring seizure frequency. Epilepsy Res 1997;27:119-25.
31. O'Brien TJ, Hanson D, O'Connor MK, et al. Subtraction ictal SPECT co-registered to MRI in partial epilepsy: description and validation of the technique with phantom and patient studies. Nucl Med Commun 1998;19:31-45.
32. Jack CR. Magnetic resonance imaging: neuroimaging and anatomy. Neuroimag Clin North Am 1995;5:597-622.
33. Marks DA, Katz A, Hoffer P, Spencer SS. Localization of extra-temporal epileptic foci during ictal single photon emission computed tomography. Ann Neurol 1992;31:250-5.
34. 99mTc-HMPAO-SPECT. Neurology 1993;43:1966-80.
35. Bairamian D, di Chiro G, Theodore WH. Epilepsy and cerebellar hypometabolism. Ann Neurol 1986;5:649.
36. Biersack HJ, Stefan H, Reichmann K, et al. HM-PAO brain SPECT and epilepsy. Nucl Med Commun 1987;8:513-8.
37. Baudrimont M, Gray F, Meininger V, Escourolle R, Castaigne P. Atrophie cérébelleuse croisée àpres lésion hémispherique survenue l'age adulte. Rev Neurol (Paris) 1983;139:485-95.
38. Duncan R, Patterson J, Hadley DM, Bone I. Unilateral cerebellar damage in focal epilepsy. JNNP 1990;53:436-7.
39. Julien RM, Laxer KD. Cerebellar responses to penicillin-induced cerebral cortical epileptiform discharge. Electroencephalogr Clin Neurophysiol 1974;37:123-32.
40. Bekkelund SI, Pierre-Jerome C, Mellgren SI. Quantitative cerebral MRI in epileptic patients. Acta Neurol Scand 1996;94:378-82.
41. Cooper IS, Upton AR. Effects of cerebellar stimulation on epilepsy, the EEG and cerebral palsy in man. Electroencephalogr Clin Neurophysiol 1978;suppl 34:349-54.
42. Hammond EJ, Wider BJ. Immunofluorescent evidence for a specific binding site for phenytoin in the cerebellum. Epilepsia 1983;24:269-74.
43. Julien RM, Halpern LM. Effects of diphenylhydantoin and other antiepileptic drugs on epileptiform activity and Purkinje cell discharge rates. Epilepsia 1972;13:387-400.
44. Shimizu H, Manaka S, Hori T, Sano K. Cerebellar electrocortigram in the control of epilepsy. Electroencephalogr Clin Neurophysiol 1977;43:507.